Provided by Tiger Trade Technology Pte. Ltd.

Cytek BioSciences

4.81
+0.15003.22%
Post-market: 4.56-0.2500-5.20%19:30 EDT
Volume:820.26K
Turnover:3.90M
Market Cap:625.22M
PE:-7.63
High:4.83
Open:4.69
Low:4.59
Close:4.66
52wk High:6.18
52wk Low:3.28
Shares:129.98M
Float Shares:103.00M
Volume Ratio:1.03
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6300
EPS(LYR):-0.5209
ROE:-23.04%
ROA:-6.31%
PB:1.94
PE(LYR):-9.23

Loading ...

Cytek Biosciences to debut Borealis 7-laser full spectrum flow cytometer at CYTO 2026

Reuters
·
Jun 03

Cytek Biosciences SVP of Global Sales and Services Philippe Busque resigns effective June 5

Reuters
·
Jun 03

Promising Penny Stocks To Consider In June 2026

Simply Wall St.
·
Jun 02

Cytek Biosciences Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
May 13

Morgan Stanley Cuts Price Target on Cytek Biosciences to $5.50 From $6, Keeps Equalweight Rating

MT Newswires Live
·
May 12

Cytek Biosciences Faces Rising Risk From U.S.–China Trade Tensions and Tariff Pressures

TIPRANKS
·
May 09

Piper Sandler Sticks to Its Buy Rating for Cytek Biosciences (CTKB)

TIPRANKS
·
May 08

Cytek Biosciences Q1 EPS $(0.15) Misses $(0.10) Estimate, Sales $44.135M Miss $44.328M Estimate

Benzinga Earnings
·
May 08

BRIEF-Cytek Biosciences Q1 Revenue USD 44.135 Million

Reuters
·
May 08

Cytek Biosciences Q1 EPS USD -0.15

THOMSON REUTERS
·
May 08

Press Release: Cytek Biosciences Reports First Quarter 2026 Financial Results

Dow Jones
·
May 08

Cytek Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
May 06

Cytek Biosciences announces annual shareholder meeting notice

Reuters
·
Apr 29

Cytek Biosciences to report first-quarter results after market close May 7

Reuters
·
Apr 24

Analysts Are Neutral on Top Healthcare Stocks: Puma Biotechnology (PBYI), Cytek Biosciences (CTKB)

TIPRANKS
·
Feb 27

Cytek Biosciences Q4 EPS $(0.34) Misses $(0.02) Estimate, Sales $62.141M Beat $57.187M Estimate

Benzinga Earnings
·
Feb 27

BRIEF-Cytek Biosciences Q4 Pretax Profit USD -4.031 Million

Reuters
·
Feb 27

Cytek Biosciences Q4 Adjusted Gross Margin 53%

THOMSON REUTERS
·
Feb 27

Cytek Biosciences Q4 Adjusted Ebitda USD 4.491 Million

THOMSON REUTERS
·
Feb 27

Press Release: Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook

Dow Jones
·
Feb 27